IOL Chemicals and Pharmaceuticals Limited (IOLCP) - Net Assets

Latest as of September 2025: Rs17.51 Billion INR ≈ $189.40 Million USD

Based on the latest financial reports, IOL Chemicals and Pharmaceuticals Limited (IOLCP) has net assets worth Rs17.51 Billion INR (≈ $189.40 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs24.13 Billion ≈ $260.97 Million USD) and total liabilities (Rs6.62 Billion ≈ $71.57 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of IOL Chemicals and Pharmaceuticals Limite to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs17.51 Billion
% of Total Assets	72.58%
Annual Growth Rate	28.9%
5-Year Change	33.9%
10-Year Change	795.12%
Growth Volatility	43.99

IOL Chemicals and Pharmaceuticals Limited - Net Assets Trend (2005–2025)

This chart illustrates how IOL Chemicals and Pharmaceuticals Limited's net assets have evolved over time, based on quarterly financial data. Also explore IOL Chemicals and Pharmaceuticals Limite assets under control for the complete picture of this company's asset base.

Annual Net Assets for IOL Chemicals and Pharmaceuticals Limited (2005–2025)

The table below shows the annual net assets of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2025. For live valuation and market cap data, see market cap of IOL Chemicals and Pharmaceuticals Limite.

Year	Net Assets	Change
2025-03-31	Rs16.88 Billion ≈ $182.51 Million	+4.73%
2024-03-31	Rs16.12 Billion ≈ $174.28 Million	+6.88%
2023-03-31	Rs15.08 Billion ≈ $163.05 Million	+8.29%
2022-03-31	Rs13.92 Billion ≈ $150.57 Million	+10.46%
2021-03-31	Rs12.60 Billion ≈ $136.31 Million	+54.93%
2020-03-31	Rs8.14 Billion ≈ $87.98 Million	+71.51%
2019-03-31	Rs4.74 Billion ≈ $51.30 Million	+119.87%
2018-03-31	Rs2.16 Billion ≈ $23.33 Million	+14.33%
2017-03-31	Rs1.89 Billion ≈ $20.41 Million	+0.09%
2016-03-31	Rs1.89 Billion ≈ $20.39 Million	-9.01%
2015-03-31	Rs2.07 Billion ≈ $22.41 Million	-0.98%
2014-03-31	Rs2.09 Billion ≈ $22.63 Million	+20.96%
2013-03-31	Rs1.73 Billion ≈ $18.71 Million	-0.35%
2012-03-31	Rs1.74 Billion ≈ $18.77 Million	+0.73%
2011-03-31	Rs1.72 Billion ≈ $18.64 Million	+16.32%
2010-03-31	Rs1.48 Billion ≈ $16.02 Million	+18.01%
2009-03-31	Rs1.26 Billion ≈ $13.58 Million	+47.86%
2008-03-31	Rs849.06 Million ≈ $9.18 Million	+157.05%
2007-03-31	Rs330.31 Million ≈ $3.57 Million	+78.06%
2006-03-31	Rs185.50 Million ≈ $2.01 Million	+76.29%
2005-03-31	Rs105.23 Million ≈ $1.14 Million	--

Equity Component Analysis

This analysis shows how different components contribute to IOL Chemicals and Pharmaceuticals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1405651660600.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs14.02 Billion	83.08%
Common Stock	Rs587.10 Million	3.48%
Other Comprehensive Income	Rs11.60 Million	0.07%
Other Components	Rs2.26 Billion	13.37%
Total Equity	Rs16.88 Billion	100.00%

IOL Chemicals and Pharmaceuticals Limited Competitors by Market Cap

The table below lists competitors of IOL Chemicals and Pharmaceuticals Limited ranked by their market capitalization.

Company	Market Cap
Asia Cement KO:002030	$299.50 Million
Sanghvi Movers Limited NSE:SANGHVIMOV	$299.52 Million
Inmobiliaria del Sur SA MC:ISUR	$299.61 Million
Colonial Coal International Corp V:CAD	$299.82 Million
Envipco Holding N.V. AS:ENVI	$299.39 Million
Fabryka Farb i Lakierów ŚNIEŻKA SA WAR:SKA	$299.34 Million
Fluxys Belgium BR:FLUX	$299.21 Million
Hyliion Holdings Corp. NYSE:HYLN	$299.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in IOL Chemicals and Pharmaceuticals Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 16,115,100,000 to 16,876,600,000, a change of 761,500,000 (4.7%).
Net income of 1,010,700,000 contributed positively to equity growth.
Dividend payments of 234,800,000 reduced retained earnings.
Other comprehensive income decreased equity by 14,400,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs1.01 Billion	+5.99%
Dividends Paid	Rs234.80 Million	-1.39%
Other Comprehensive Income	Rs-14.40 Million	-0.09%
Total Change	Rs-	4.73%

Book Value vs Market Value Analysis

This analysis compares IOL Chemicals and Pharmaceuticals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 8.21x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 36.08x to 8.21x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-03-31	Rs2.61	Rs94.32	x
2006-03-31	Rs3.93	Rs94.32	x
2007-03-31	Rs8.03	Rs94.32	x
2008-03-31	Rs10.43	Rs94.32	x
2009-03-31	Rs15.56	Rs94.32	x
2010-03-31	Rs13.84	Rs94.32	x
2011-03-31	Rs14.06	Rs94.32	x
2012-03-31	Rs13.37	Rs94.32	x
2013-03-31	Rs13.25	Rs94.32	x
2014-03-31	Rs15.37	Rs94.32	x
2015-03-31	Rs10.34	Rs94.32	x
2016-03-31	Rs7.03	Rs94.32	x
2017-03-31	Rs6.71	Rs94.32	x
2018-03-31	Rs7.68	Rs94.32	x
2019-03-31	Rs16.88	Rs94.32	x
2020-03-31	Rs28.54	Rs94.32	x
2021-03-31	Rs43.22	Rs94.32	x
2022-03-31	Rs47.44	Rs94.32	x
2023-03-31	Rs51.37	Rs94.32	x
2024-03-31	Rs54.90	Rs94.32	x
2025-03-31	Rs11.49	Rs94.32	x

Capital Efficiency Dashboard

This dashboard shows how efficiently IOL Chemicals and Pharmaceuticals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.99%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.89%
• Asset Turnover: 0.87x
• Equity Multiplier: 1.41x
Recent ROE (5.99%) is below the historical average (13.44%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	53.33%	6.72%	1.39x	5.71x	Rs45.60 Million
2006	39.12%	4.78%	1.60x	5.10x	Rs54.02 Million
2007	22.86%	3.73%	1.15x	5.35x	Rs42.48 Million
2008	14.56%	3.91%	1.31x	2.84x	Rs38.73 Million
2009	10.11%	4.21%	0.72x	3.34x	Rs1.40 Million
2010	6.76%	2.87%	0.69x	3.43x	Rs-48.00 Million
2011	3.59%	1.59%	0.64x	3.54x	Rs-110.55 Million
2012	2.74%	1.01%	0.69x	3.96x	Rs-126.07 Million
2013	0.92%	0.33%	0.66x	4.20x	Rs-157.11 Million
2014	1.58%	0.59%	0.76x	3.54x	Rs-176.26 Million
2015	-32.17%	-17.32%	0.55x	3.39x	Rs-873.71 Million
2016	-21.62%	-6.90%	0.75x	4.19x	Rs-585.39 Million
2017	2.47%	0.67%	0.86x	4.33x	Rs-142.00 Million
2018	12.84%	2.88%	1.13x	3.95x	Rs61.26 Million
2019	49.90%	14.04%	1.79x	1.99x	Rs1.89 Billion
2020	44.41%	19.07%	1.62x	1.44x	Rs2.80 Billion
2021	35.27%	22.84%	1.21x	1.28x	Rs3.19 Billion
2022	12.04%	7.68%	1.11x	1.41x	Rs284.22 Million
2023	9.23%	6.32%	1.09x	1.34x	Rs-116.32 Million
2024	8.34%	6.34%	0.94x	1.39x	Rs-267.21 Million
2025	5.99%	4.89%	0.87x	1.41x	Rs-676.96 Million

Industry Comparison

This section compares IOL Chemicals and Pharmaceuticals Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $23,713,303,062
Average return on equity (ROE) among peers: 8.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
IOL Chemicals and Pharmaceuticals Limited (IOLCP)	Rs17.51 Billion	53.33%	0.38x	$299.41 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$5.85 Billion
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About IOL Chemicals and Pharmaceuticals Limited

NSE:IOLCP India Drug Manufacturers - Specialty & Generic

Market Cap

$299.41 Million

Rs27.69 Billion INR

Market Cap Rank

#14969 Global

#738 in India

Share Price

Rs94.32

Change (1 day)

-1.37%

52-Week Range

Rs62.20 - Rs119.93

All Time High

Rs840.03